# Evaluation of the Added Clinical Value of Donor-derived Cell-free DNA for the Monitoring of Cardiac Allograft Rejection.

> **NCT06740578** · — · COMPLETED · sponsor: **Paris Translational Research Center for Organ Transplantation** · enrollment: 320 (actual)

## Conditions studied

- Heart Transplantation
- Rejection Heart Transplant

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06740578
- **Lead sponsor:** Paris Translational Research Center for Organ Transplantation
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-01
- **Primary completion:** 2023-10-31
- **Final completion:** 2023-10-31
- **Target enrollment:** 320 (ACTUAL)
- **Last updated:** 2025-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06740578

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06740578, "Evaluation of the Added Clinical Value of Donor-derived Cell-free DNA for the Monitoring of Cardiac Allograft Rejection.". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06740578. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*